-
The FDA has approved a new drug for the management of alcohol dependence.
-
-
Sources of funding for pharmaceutical research has come under scrutiny in the last decade as academic and government sources of funding have become increasingly scarce and the pharmaceutical industry has become the main source of research dollars. But the issue of objectivity has been raised, and some have even suggested that negative studies, that is studies that show a drug in an unfavorable light, may never be published. The American Medical Association has recently tackled this issue and has asked the department of Health and Human Services to establish a public registry of all clinical trials in United States.
-
-
End-stage renal disease is a devastating condition that, according to the United States Renal Data System, plagued approximately 406,000 individuals in the United States in 2001 and is projected to increase to a prevalence of approximately 725,000 by 2010. Furthermore, it is a major public health issue, given the overall poor outcomes and high costs for this chronic condition.
-
Normal PSA levels in elderly men should not be cause for reassurance that cancer does not exist. A rise in PSA level at any range should be a cause for concern about cancer.
-
Moderate alcohol consumption is associated with a decreased incidence of diabetes mellitus and a decrease in heart disease in persons with diabetes.
-
Dietary calcium, phytate, and fluid intake are associated with a decreased risk of symptomatic nephrolithiasis in younger women.
-
The present results on the Cache County study provide some of the strongest evidence to date that intake of antioxidant vitamin supplements may be beneficial.
-
The FDA has approved an injectable drug for treating Parkinsons patients during hypomobility periods known as off periods.